Use of angiotensin-converting-enzyme inhibitor is related to improvement of all-cause mortality in patients with maintenance hemodialysis
Author:
Affiliation:
1. Department of Internal Medicine, Medical Center East, Tokyo Women’s Medical University
2. Department of Internal Medicine, Yoshikawa Clinic
3. 4th Department of Internal Medicine, Tokyo Women’s Medical University
Publisher
Japanese Society for Dialysis Therapy
Subject
Organic Chemistry,Biochemistry
Reference28 articles.
1. 3) Collins AJ. Influence of target hemoglobin in dialysis patients on morbidity and mortality. Kidney Int 2002; 80 (Suppl): 44-8.
2. 4) Kovesdy CP, Bleyer AJ, Molnar MZ, et al. Blood pressure and mortality in U. S. veterans with chronic kidney disease: a cohort study. Ann Intern Med 2013; 159: 233-42.
3. 5) Noordzij M, Korevaar JC, Dekker FW, et al. NECOSAD study group. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline. Blood Purif 2008; 26: 231-7.
4. 6) Zannad F, Kessler M, Lehert P, et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int 2006; 70: 1318-24.
5. 7) Iseki K, Arima H, Kohagura K, et al. Olmesartan Clinical Trial in Okinawan Patients Under OKIDS (OCTOPUS) Group. Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial. Nephrol Dial Transplant 2013; 28: 1579-89.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3